Van Strydonck, Gerald E. 4
4 · VACCINEX, INC. · Filed May 17, 2019
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Van Strydonck, Gerald E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-05-15+7,718→ 7,718 totalExercise: $7.78From: 2020-05-15→ Common Stock (7,718 underlying)
Holdings
- 7,500
Stock Option (Right to Buy)
Exercise: $14.90Exp: 2023-03-06→ Common Stock (7,500 underlying) - 6,396
Stock Option (Right to Buy)
Exercise: $13.60Exp: 2027-09-15→ Common Stock (6,396 underlying) - 2,501
Stock Option (Right to Buy)
Exercise: $5.26Exp: 2029-03-30→ Common Stock (2,501 underlying) - 4,500
Stock Option (Right to Buy)
Exercise: $10.00Exp: 2020-03-06→ Common Stock (4,500 underlying)
Footnotes (2)
- [F1]Exercisable in full as of the date of this report.
- [F2]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.